2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee

Partnering Events:

TechConnect Summit
Clean Technology 2008

Pharmacokinetic Optimization of Phage Particles for Gene-Delivery

Andrew Baird

Andrew Baird

University of California at San Diego

Andrew Baird—Professor at University of California at San Diego—received PhD in biochemistry (McGill University, Montreal Canada, 1979) and did his post doctoral fellowship at the Salk Institute for Biological Studies where he remained on faculty until 1990 until becoming Professor at The Scripps Institutes for Medical Sciences. In 1995, he moved his laboratories to Prizm Pharmaceuticals (later Selective Genetics) where he led the drug discovery and drug development R&D groups. After moving a small molecule drug, a peptide therapeutic and gene based medicine from discovery and into pre-clinical and later clinical development, in 2001 he assumed a Professorship and the Directorship of the Sackler Institute of Pharmaceutical Sciences at Kings’ College, London. He is now Professor of Surgical Pharmaceutics in the University of California San Diego School of Medical Sciences.

Dr Baird is the inventor on over 40 issued US patents and the recipient of awards from the Japanese Inflammation Society (Tokyo), the Kroc Lecture (Miami), The Sister Mary Doyle Lecture (London) and MGSS (Montreal). His work has been currently funded with grants from the Department of Defense (gene medicine delivery), CDMRP and CBCRP (cancer stem cells and metastasis), and the NIH (CNS drug delivery and wound healing). He is currently the Director of one of four NIH funded Centers for Innovation in Wound Healing Research. His major research interests include targeted drug and gene delivery, phage nanobiotechnology, CNS drug delivery, biotherapeutics development and growth factors. www.ciwhr.org)

Speaking in the special symposium on Phage Nanobiotechnology.

View Confimed Speakers

← Back to Conferences & Symposia